z-logo
open-access-imgOpen Access
INFLUENCE OF THE COMBINATION OF PASAK BUMI ROOT AND PROPOLIS EXTRACTS ON PARASITEMIA LEVELS IN MICE INFECTED WITH PLASMODIUM BERGHEI
Author(s) -
Nur Hasanah,
Hendri Astuty
Publication year - 2019
Publication title -
international journal of applied pharmaceutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.238
H-Index - 15
ISSN - 0975-7058
DOI - 10.22159/ijap.2019.v11s1.015
Subject(s) - parasitemia , propolis , plasmodium berghei , artemisinin , malaria , traditional medicine , positive control , combination therapy , medicine , body weight , pharmacology , plasmodium falciparum , immunology
Objective: Malaria infection remains a global concern due to increasing resistance to artemisinin-based combination therapy. This study examinedthe antimalarial effects of propolis extract alone and in combination with pasak bumi root extract.Methods: In the study, 30 mice were divided into six groups including two control groups, two groups of mice treated with propolis aloneat concentrations of 90 and 180 mg/kg body weight (BW), and two combination groups of mice treated with 90 or 180 mg/kg BW propolis incombination with 60 or 75 mg/kg BW pasak bumi, respectively. Plasmodium berghei 2% was injected into each mouse, and blood smears wereprepared after 8 days to assess parasitemia.Results: The results revealed no significant difference in parasitemia levels between the positive control and the two combination groups (p=0.136 and0.289, respectively). However, superior growth inhibition (GI) results were observed in the combination groups (97.97% and 97.83%, respectively)than in the propolis monotherapy groups, whereas better outcomes were observed in the positive control group (98.63% GI) than in the propolismonotherapy groups (23.88% and 51.66%, respectively).Conclusion: These results illustrate that combination therapy is superior to propolis monotherapy in inhibiting parasitemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here